← FDA DRUG APPROVALS

FDA NDA · NDA010742

COMPAZINE

Sponsor: GLAXOSMITHKLINE

APPLICATION
NDA010742
TYPE
NDA
ORIGINAL APPROVAL
1957-04-08
LATEST ACTION
2001-04-03
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

COMPAZINE · ReferenceDiscontinued
PROCHLORPERAZINE EDISYLATE EQ 5MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · INJECTABLE · INJECTION

Approval history

2001-04-03Labeling · Supplement 65 · standard — Letter ↗AP
1979-08-21Labeling · Supplement 31AP
1957-04-08Type 2 - New Active Ingredient · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →